文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

Pareto导航引导的自动化放疗计划在前列腺癌中的应用评估

Evaluating the application of Pareto navigation guided automated radiotherapy treatment planning to prostate cancer.
PubMed 文献 · Radiother Oncol · 2019-09-13

本研究评估了一种基于Pareto导航原则校准的新型自动化放疗计划方案,对40例前列腺癌患者(20例前列腺及精囊腺PSV、20例前列腺及盆腔淋巴结PPN)自动生成VMAT计划(VMATAuto),与临床条件及无时间压力下人工计划比较。盲审显示39/40和33/40的VMATAuto计划分别优于或等于VMATClinical和VMATIdeal,全部临床可接受,且剂量学相似,PSV和PPN手工计划时间分别减少94%和79%。

要点

  • VMATAuto计划全部临床可接受,盲审多优于或等于人工计划。
  • 剂量学与人工计划相似,差异临床意义普遍较低。
  • PSV手工计划时间减少94%,PPN减少79%。

核心结论

  • 基于Pareto导航校准的自动化计划方案可直观纳入权衡决策,成功应用于两种复杂程度不同的靶区,高效稳健生成高质量计划。

研究设计与样本

  • 随机选取40例前列腺癌患者,20例PSV和20例PPN,比较自动生成VMATAuto计划与临床条件及无时间压力下人工计划。
  • 采用剂量学参数定量比较与肿瘤科医生盲审进行评价。

主要发现

  • 盲审中39/40和33/40的VMATAuto计划分别被认为优于或等于VMATClinical和VMATIdeal,全部临床可接受。
  • VMATAuto、VMATClinical和VMATIdeal剂量学相似,观察到的差异临床意义普遍较低。
  • 相较VMATClinical,VMATAuto使PSV和PPN手工计划时间分别减少94%和79%。
  • PSV总计划时间从22.2分钟显著降至14.0分钟,PPN未见显著减少。

临床怎么用

  • 该方案可用于前列腺癌(含或不含 elective 淋巴结照射)自动计划,减少手工计划时间并保持临床可接受质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Current automated planning methods do not allow for the intuitive exploration of clinical trade-offs during calibration. Recently a novel automated planning solution, which is calibrated using Pareto navigation principles, has been developed to address this issue. The purpose of this work was to clinically validate the solution for prostate cancer patients with and without elective nodal irradiation. MATERIALS AND METHODS: For 40 randomly selected patients (20 prostate and seminal vesicles (PSV) and 20 prostate and pelvic nodes (PPN)) automatically generated volumetric modulated arc therapy plans (VMATAuto) were compared against plans created by expert dosimetrists under clinical conditions (VMATClinical) and no time pressures (VMATIdeal). Plans were compared through quantitative comparison of dosimetric parameters and blind review by an oncologist. RESULTS: Upon blind review 39/40 and 33/40 VMATAuto plans were considered preferable or equal to VMATClinical and VMATIdeal respectively, with all deemed clinically acceptable. Dosimetrically, VMATAuto, VMATClinical and VMATIdeal were similar, with observed differences generally of low clinical significance. Compared to VMATClinical, VMATAuto reduced hands-on planning time by 94% and 79% for PSV and PPN respectively. Total planning time was significantly reduced from 22.2 mins to 14.0 mins for PSV, with no significant reduction observed for PPN. CONCLUSIONS: A novel automated planning solution has been evaluated, whose Pareto navigation based calibration enabled clinical decision-making on trade-off balancing to be intuitively incorporated into automated protocols. It was successfully applied to two sites of differing complexity and robustly generated high quality plans in an efficient manner.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Wheeler PA, Chu M, Holmes R, et al. Evaluating the application of Pareto navigation guided automated radiotherapy treatment planning to prostate cancer. Radiother Oncol. 2019. PMID: 31526670. doi:10.1016/j.radonc.2019.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。